MICA and neoplasm: Furthermore, pharmacologic inhibition of MICA/B shedding enhances antitumor immunity and controls tumor growth in animal models (17), suggesting that inhibition of shed NKG2DLs may be a promising mechanism to reinvigorate antitumor immunity.